Stephan Krähenbühl

18PUBLICATIONS
26CO-AUTHORS
PharmacogenomicsEpigenetics (incl. genome methylation and epigenomics)Medical biochemistry - lipidsPredictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Apr 23, 2024
Physiologically Based Pharmacokinetic Modeling to Predict the Impact of Liver Cirrhosis on Glucuronidation via UGT1A4 and UGT2B7/2B4-A Case Study with Midazolam.

Agustos C Ozbey, Janneke Keemink, Bjoern Wagner

|Mar 11, 2023
Rats with Long-Term Cholestasis Have a Decreased Cytosolic but Maintained Mitochondrial Hepatic CoA Pool.

Lukas Krähenbühl, Stephan Krähenbühl

|Oct 27, 2022
PGC-1α and MEF2 Regulate the Transcription of the Carnitine Transporter OCTN2 Gene in C2C12 Cells and in Mouse Skeletal Muscle.

Katerina Novakova, Michael Török, Miljenko Panajatovic

|Feb 26, 2022
Mitochondrial Toxicity Associated with Imatinib and Sorafenib in Isolated Rat Heart Fibers and the Cardiomyoblast H9c2 Cell Line.

Jamal Bouitbir, Miljenko V Panajatovic, Stephan Krähenbühl

|Oct 14, 2021
Cytochrome P450 1A2 is the most important enzyme for hepatic metabolism of the metamizole metabolite 4-methylaminoantipyrine.

Fabio Bachmann, Henriette E Meyer Zu Schwabedissen, Urs Duthaler

Pageof 3